Puma Biotechnology Investor Relations Material

Puma Biotechnology Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of cancer. The company specializes in targeted oncology, developing drugs that aim to improve outcomes for patients with specific types of cancer by addressing unmet medical needs. It collaborates with healthcare professionals, researchers, and regulatory bodies to advance its clinical and commercial objectives. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.